Input 2021.02.01 17:48 | Revision 2021.02.01 18:40
Medical Association “In the case of elderly people, Pfizer, Moder or vaccination is required”
On the 1st, the president of the Korean Medical Association said, “The US Food and Drug Administration (FDA) is in the process of approving AstraZeneca vaccine, and the European Union’s Drug Administration (EMA) is also effective in the elderly over 55 years of age. Although this was not sufficiently proven, it recommended vaccination for the elderly,” he said. “The Korea Medical Association has reviewed the efficacy and safety of the AstraZeneca vaccine and judged that the efficacy for the elderly over the age of 65 has not been proven.”
In the case of AstraZeneca’s vaccine, the efficacy of the vaccine has not been proven in the elderly, so some medical claims should not be given. Chairman Choi Ji-jip said, “AstraZeneca vaccine should be vaccinated for adults aged 18 to 64, and should not be vaccinated for seniors over 65 years of age.” He added, “In the case of elderly people 65 years of age or older, there is a high possibility that they will be severely affected by Corona 19 infection,” he said. “The Pfizer Modena vaccine, which is the most effective and proven vaccine to date, should be inoculated.”
In fact, the international community has pointed out that AstraZeneca’s Corona 19 vaccine requires additional verification due to the lack of clinical data for seniors compared to Pfizer and Modena vaccines previously approved by the FDA. In some European countries, such as Germany and France, recommendations have been made that the elderly should be excluded from the vaccine. For example, the immunization committee under the Robert Koch Institute (RKI) of the German Centers for Disease Control and Prevention (RKI) said that the vaccine was only 8% effective for those over 65 years old, and said, “Only those aged 18 to 64 should get the AstraZeneca vaccine.” It differs somewhat from the position of the European Medicines Agency (EMA), which recommends conditional approval of this vaccine and that it can be used in the elderly.
On the other hand, the Korean Ministry of Food and Drug Safety said that a number of experts expressed the opinion that the AstraZeneca Corona 19 vaccine can be vaccinated against the elderly over the age of 65. According to the Ministry of Food and Drug Safety, as a result of evaluating the preventive effect of 660 elderly people, only one patient with mild infection after vaccination. It was found that there was no significant difference in the indicators indicating the preventive effect at all ages. It is explained that the incidence of adverse reactions after vaccination in the elderly was similar to or lower than that of adults under the age of 65, even in a safety test that evaluated 2109 elderly people. An official from the Ministry of Food and Drug Safety also commented, “The preventive effect has not been proven due to insufficient data on the high-risk elderly, and the neutralizing antibody price is lower than that of adults under the age of 65, so it is desirable to confirm additional clinical results and then reflect them in the license.” There was” he explained.
In the midst of such confusion, public unrest without even a vaccine option is growing. Some say, “I don’t even have the right to choose a vaccine, but the elderly are concerned if a problem occurs.” In this regard, the government’s COVID-19 vaccination response team said, “In a situation where various types of vaccines are supplied, in order to safely vaccinate as many people as possible as soon as possible, vaccinations are conducted according to the order of vaccination rather than the type of vaccine, thereby confounding the vaccination site It is necessary to minimize it.” In principle, the promotion team decided that if vaccination was deliberately refused, if the vaccination was not scheduled within the deadline, the vaccination ranking would be ranked after the vaccination.
Chairman Choi said, “Vaccination that has not been proven effective is contrary to the purpose of vaccination to reduce mortality through preferential vaccination for the elderly. We expect a reasonable conclusion based on medical evidence from the Ministry of Food and Drug Safety.” Raised.